Trending...
- Stigma Across Borders: Concerns Grow Over Discrimination Against Shincheonji Members Abroad
- Silent Gum Disease Can Harm More Than Your Smile, Says Salem Dentist Dr. Jeffrey Casiglia
- World Cup Crowds Are a Stress Test for America's Restrooms
BOSTON - BostonChron -- Boston, MA — Today marks the official launch of Sesen, a next-generation language services company purpose-built to meet the complex demands of the life sciences industry. Specializing exclusively in translation, localization, and AI-enhanced linguistic solutions for pharmaceutical, biotechnology, medical device, CRO, and regulatory organizations, Sesen combines industry expertise with cutting-edge technology to deliver faster, more accurate, and fully compliant multilingual communications across 150+ languages.
Built by industry veterans, Sesen is redefining how global life sciences companies manage language workflows—from clinical trial documentation and regulatory labeling to patient communications and digital health platforms. At the core of its offering is SesenGPT (https://www.sesen.com/sesengpt/), a proprietary AI engine trained on life sciences terminology and optimized for medical and regulatory content.
Key Capabilities Include:
"Life sciences innovation is increasingly global, but language remains a critical barrier," said Dr. Vladimir Misik, VP of Global Clinical Trial Strategy at Sesen. "We launched Sesen to solve this challenge with unmatched specialization, seamless technology integration, and the linguistic precision this industry demands."
More on Boston Chron
Diego Di Leva, Sesen's VP of Global Operations and Strategic Partnership, and a certified ISO 9001 and ISO 13485 auditor, added:
"At Sesen, language quality is not an afterthought—it's built into the DNA of every project. Our quality assurance framework is grounded in international standards and supported by linguists with deep domain expertise, ensuring every deliverable meets the highest regulatory and scientific expectations."
With a growing network of professional linguists, in-country reviewers, and regulatory consultants, Sesen is already supporting top-10 pharmaceutical and biotechnology companies with compliant, on-time delivery of multilingual assets for global product launches, international clinical trials, and worldwide regulatory submissions.
To learn more about Sesen or to request a quote, visit www.sesen.com.
Media Contact:
Nikki Andrews
press@sesen.com
About Sesen
Sesen is a specialized language solutions provider exclusively serving the life sciences industry. With a focus on clinical, regulatory, and commercial translation services, Sesen supports pharmaceutical, biotech, medical device, and CRO clients in over 150 languages. The company combines expert native linguists, medical professionals, and ISO-certified workflows with proprietary AI technology to deliver faster, more accurate, and fully compliant multilingual content. From global clinical trial support to in-market product localization, Sesen enables life sciences organizations to operate with linguistic confidence and regulatory precision worldwide.
More on Boston Chron
Built by industry veterans, Sesen is redefining how global life sciences companies manage language workflows—from clinical trial documentation and regulatory labeling to patient communications and digital health platforms. At the core of its offering is SesenGPT (https://www.sesen.com/sesengpt/), a proprietary AI engine trained on life sciences terminology and optimized for medical and regulatory content.
Key Capabilities Include:
- Regulatory-compliant translations aligned with EMA, FDA, and PMDA guidelines
- ISO 17100, ISO 9001:2015, and ISO 13485:2016 certified quality management
- AI-enabled hybrid workflows for clinical trial translations (https://www.sesen.com/clinical-trial-translation-services/), pharmacovigilance (https://www.sesen.com/pharmaceutical-manufacturing-translation/), and labeling (https://www.sesen.com/labeling-translation-serv...)
- Native linguists and MD/PhD medical reviewers for domain-specific accuracy
- Scalable language solutions integrated with sponsor CMS and eTMF systems
"Life sciences innovation is increasingly global, but language remains a critical barrier," said Dr. Vladimir Misik, VP of Global Clinical Trial Strategy at Sesen. "We launched Sesen to solve this challenge with unmatched specialization, seamless technology integration, and the linguistic precision this industry demands."
More on Boston Chron
- Intercontinental Real Estate Corporation Acquires Retail Center Near Seattle WA for $69.5 Million
- EyeCool Therapeutics Announces Publication of Positive Clinical Study Results for Its COSP Device
- Is the Market Missing One of the Most Undervalued Cybersecurity Companies on the Stock Market? Cycurion, Inc. (N A S D A Q: CYCU):
- Billion-Dollar Scale Global Technology Powerhouse Being Built with Expanding Government Contracts: Circle8 Group (N A S D A Q: CIRC)
- Nevada Boxing Hall of Fame Gears Up for Star-Studded 14th Annual Induction Gala Weekend
Diego Di Leva, Sesen's VP of Global Operations and Strategic Partnership, and a certified ISO 9001 and ISO 13485 auditor, added:
"At Sesen, language quality is not an afterthought—it's built into the DNA of every project. Our quality assurance framework is grounded in international standards and supported by linguists with deep domain expertise, ensuring every deliverable meets the highest regulatory and scientific expectations."
With a growing network of professional linguists, in-country reviewers, and regulatory consultants, Sesen is already supporting top-10 pharmaceutical and biotechnology companies with compliant, on-time delivery of multilingual assets for global product launches, international clinical trials, and worldwide regulatory submissions.
To learn more about Sesen or to request a quote, visit www.sesen.com.
Media Contact:
Nikki Andrews
press@sesen.com
About Sesen
Sesen is a specialized language solutions provider exclusively serving the life sciences industry. With a focus on clinical, regulatory, and commercial translation services, Sesen supports pharmaceutical, biotech, medical device, and CRO clients in over 150 languages. The company combines expert native linguists, medical professionals, and ISO-certified workflows with proprietary AI technology to deliver faster, more accurate, and fully compliant multilingual content. From global clinical trial support to in-market product localization, Sesen enables life sciences organizations to operate with linguistic confidence and regulatory precision worldwide.
More on Boston Chron
- New Thriller 'Counterframe' Explores the Hidden Vulnerabilities of Modern Society
- Award-Winning Heritage at South Brunswick Continues to Thrive as One of New Jersey's Premier New Home Communities
- Four Seasons Cleaners Debuts Santa Barbara County's First 24/7 Dry Cleaning Kiosk New self-service
- WhereTu Launches to Help Americans Build Successful Lives Abroad
- Boston: Mayor Michelle Wu Announces Launch of Summer Meal Sites Across the City Providing Healthy Meals At No Cost To Youth
Source: CSOFT International, Inc.
0 Comments
Latest on Boston Chron
- Able Rooter Expands Services to Offer Premium Water Heater Installation Across St. Louis
- Director Sean McNamara Reunites with Award-Winning Cinematographer Shawn Seifert for Upcoming Feature Home
- J. Kenton Pierce Wins Prometheus Award for Best Novel
- Office of Youth Engagement and Advancement Announce Third Summer of Boston After Dark Programming
- Class is in session: Black Beauty Block Party returns to Los Angeles for fourth annual festival
- Heavy Duty Journal Surpasses 1000 Technical Articles for Diesel Technicians and Fleet Managers
- Solar Dave MA Expands Beyond the South Shore to Serve All of Massachusetts, Rhode Island, and NH
- Kolbus Introduces the Next Step in Casemaking Efficiency
- Silent Gum Disease Can Harm More Than Your Smile, Says Salem Dentist Dr. Jeffrey Casiglia
- Florida Law Advisers, P.A. Named Best Divorce Firm of 2026 by Expert Law Attorneys
- Boston: West Nile Virus Detected in Mosquito Test Sample in Jamaica Plain
- Mayor Michelle Wu and Boston Parks and Recreation Announce Boston Family Golf Nights at City Golf Courses
- L-Tron to attend the 2026 National District Attorneys Association Annual Conference
- Sounds of LA County: 27 Parks.108 Concerts. One County
- Only One Flight Stands Between Los Angeles Youth Leaders and a Life-Saving Mission in South Africa
- Boston: Mayor Michelle Wu Urges Caution as Warm Weather Forecasted Throughout the Week
- Stigma Across Borders: Concerns Grow Over Discrimination Against Shincheonji Members Abroad
- World Cup Crowds Are a Stress Test for America's Restrooms
- Postmortem Pathology Expands Access to Private Autopsy Services in Las Vegas
- Boston: $600,000 in New Grant Funding to Prevent Community Overdose Deaths and Expand Access to Treatment